2.87
Nyxoah Sa stock is traded at $2.87, with a volume of 106.42K.
It is up +0.00% in the last 24 hours and down -6.51% over the past month.
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.
See More
Previous Close:
$2.87
Open:
$2.81
24h Volume:
106.42K
Relative Volume:
2.06
Market Cap:
$128.27M
Revenue:
$11.51M
Net Income/Loss:
$-101.84M
P/E Ratio:
-1.0743
EPS:
-2.6714
Net Cash Flow:
$-82.98M
1W Performance:
-6.82%
1M Performance:
-6.51%
6M Performance:
-37.88%
1Y Performance:
-65.50%
Nyxoah Sa Stock (NYXH) Company Profile
Name
Nyxoah Sa
Sector
Industry
Phone
-
Address
-
Compare NYXH vs ISRG, BDX, ALC, MDLN, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
NYXH
Nyxoah Sa
|
2.87 | 128.27M | 11.51M | -101.84M | -82.98M | -2.6714 |
|
ISRG
Intuitive Surgical Inc
|
438.10 | 155.76B | 10.58B | 3.00B | 2.83B | 8.2437 |
|
BDX
Becton Dickinson Co
|
147.63 | 40.30B | 21.37B | 1.41B | 3.07B | 3.9437 |
|
ALC
Alcon Inc
|
67.78 | 33.13B | 10.63B | 819.00M | 1.59B | 1.6577 |
|
MDLN
Medline Inc
|
37.01 | 31.37B | 29.14B | 1.07B | 1.05B | 1.1956 |
|
RMD
Resmed Inc
|
208.05 | 30.31B | 5.54B | 1.52B | 1.74B | 10.37 |
Nyxoah Sa Stock (NYXH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-31-23 | Initiated | H.C. Wainwright | Buy |
| Jul-19-23 | Initiated | Robert W. Baird | Neutral |
| Apr-21-22 | Initiated | Oppenheimer | Outperform |
| Apr-06-22 | Initiated | Wolfe Research | Peer Perform |
| Dec-21-21 | Resumed | Cantor Fitzgerald | Overweight |
| Jul-28-21 | Initiated | Cantor Fitzgerald | Overweight |
View All
Nyxoah Sa Stock (NYXH) Latest News
Nyxoah Q1 earnings call highlights - MSN
Nyxoah Q1 2026 Earnings: Narrower-Than-Expected Loss Highlights Continued ProgressFinal Results - Newser
Nyxoah SA (NYXH) Stock Analysis: Flat at $2.90, What's Next 2026-05-21Linear Regression - Newser
Nyxoah SA (NYXH) Delivers Q1 2026 Beat — EPS $-0.37 vs $-0.51 ExpectedTrending Volume Leaders - Newser
Nyxoah details 44.7m voting shares, up to 8.6m via bonds - Stock Titan
Nyxoah Welcomes the Flemish Investors Federation (VFB) at - GlobeNewswire
Nyxoah SA Earnings Call Highlights Growth And Strain - TipRanks
Nyxoah SA (NYXH) Fell -3.92% — Is a Recovery Ahead? 2026-05-19Bear Flag - Newser
Nyxoah SA (NYXH) Stock: Slides -4.10%, Support at $2.67 2026-05-19Trending Momentum Stocks - Newser
Analysts Are Upgrading Nyxoah SA (EBR:NYXH) After Its Latest Results - simplywall.st
Nyxoah SAOrdinary Shares (NQ: NYXH - FinancialContent
Earnings call transcript: Nyxoah Q1 2026 sees strong U.S. growth, stock dips - Investing.com Nigeria
Transcript : Nyxoah SA Presents at Bank of America Global Healthcare Conference 2026, May-13-2026 05 - marketscreener.com
NYXH: Rapid U.S. commercialization and strong clinical results drive growth in sleep apnea neuromodulation - TradingView
Nyxoah Earnings Call: Growth Surges Amid Cash Strain - TipRanks
Piper Sandler cuts Nyxoah stock price target on balance sheet concerns - Investing.com UK
Piper Sandler cuts Nyxoah stock price target on balance sheet concerns By Investing.com - Investing.com India
This Toast Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday - Sahm
Nyxoah SA Stock 12‑Month Price Target Cut to $9.16, Implies 198% Upside - TradingView
Nyxoah S.A. (NASDAQ:NYXH) Q1 2026 Earnings Call Transcript - Insider Monkey
Nyxoah SA Stock 12‑Month Price Target Cut to $9.19, Implies 199% Upside - TradingView
Nyxoah Reports Q1 2026 Results: Full Earnings Call Transcript - Sahm
Earnings Call Summary | Nyxoah SA(NYXH.US) Q1 2026 Earnings Conference - Moomoo
Nyxoah Q1 Earnings Call Highlights - sharewise.com
Nyxoah SA (NYXH) reports Q1 loss, tops revenue estimates - MSN
Nyxoah SA reports results for the quarter ended March 31Earnings Summary - TradingView
Nyxoah SA (NYXH) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
Earnings call transcript: Nyxoah Q1 2026 sees strong U.S. growth, stock dips By Investing.com - Investing.com South Africa
Nyxoah Calls June 10 Shareholder Meetings and Files Q1 2026 Results - TipRanks
Nyxoah Reports First Quarter 2026 Financial and Operating Results - The Manila Times
NYXH: Q1 2026 net revenue rose to €6.4M, driven by U.S. Genio launch and robust reimbursement - TradingView
Nyxoah (Nasdaq: NYXH) posts Q1 2026 surge in revenue but flags funding risk - Stock Titan
Nyxoah : Q1 Report 2026 - marketscreener.com
Stifel cuts Nyxoah stock rating on reimbursement challenges By Investing.com - Investing.com Australia
Stifel cuts Nyxoah stock rating on reimbursement challenges - Investing.com
symbol__ Stock Quote Price and Forecast - CNN
Stifel Maintains Nyxoah SA(NYXH.US) With Buy Rating, Cuts Target Price to $10 - Moomoo
Nyxoah to let registered holders follow June 10 meetings by video - Stock Titan
Invitation to attend the annual and the extraordinary - GlobeNewswire
Nyxoah SA (NYXH) may report negative earnings: Know the trend ahead of next week's release - MSN
Earnings Preview: Nyxoah SA to Report Financial Results on May 12 - 富途牛牛
What makes Nyxoah SA (NYXH) a safer bet than newer entrants (-0.62%) 2026-05-07Investment Picks - Newser
Nyxoah SA (NYXH) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - Yahoo Finance
How The Nyxoah (ENXTBR:NYXH) Narrative Is Shifting With CMS Codes And Trimmed Targets - Yahoo Finance
Nyxoah (NYXH) Earnings Date and Reports 2026 - MarketBeat
Nyxoah : to Participate in the Bank of America 2026 Healthcare Conference - marketscreener.com
Latest NYXH NewsNyxoah Announces Pricing of Nasdaq Public O... - Stock Titan
Nyxoah to Participate in the Bank of America 2026 Healthcare Conference - The Manila Times
Nyxoah (NYXH) Jefferies 2024 Global Healthcare Conference Summary - Quartr
Nyxoah (NYXH) 2024 Cantor Fitzgerald Global Healthcare Conference Summary - Quartr
Nyxoah to Release First Quarter 2026 Financial Results on May 12, 2026 - Sahm
Nyxoah Sa Stock (NYXH) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):